Alzheimer's disease genetics: From the bench to the clinic

Celeste M. Karch, Carlos Cruchaga, Alison M. Goate

Research output: Contribution to journalReview articlepeer-review

356 Scopus citations


Alzheimer's disease (AD) is a clinically heterogeneous neurodegenerative disease with a strong genetic component. Several genes have been associated with AD risk for nearly 20 years. However, it was not until the recent technological advances that allow for the analysis of millions of polymorphisms in thousands of subjects that we have been able to advance our understanding of the genetic complexity of AD susceptibility. Genome-wide association studies and whole-exome and whole-genome sequencing have revealed more than 20 loci associated with AD risk. These studies have provided insights into the molecular pathways that are altered in AD pathogenesis, which have, in turn, provided insight into novel therapeutic targets. Karch etal. discuss how the recent technological advances in human genetics have led to an increased understanding of the genetic architecture and molecular pathways involved in Alzheimer's disease.

Original languageEnglish
Pages (from-to)11-26
Number of pages16
Issue number1
StatePublished - 2 Jul 2014
Externally publishedYes


Dive into the research topics of 'Alzheimer's disease genetics: From the bench to the clinic'. Together they form a unique fingerprint.

Cite this